Oncology

Kinase inhibitors sorafenib and sunitinib found no more effective than placebo preventing disease recurrence after kidney tumor removal surgery.

Learning what doesn't work in the treatment of cancer still offers valuable insight.

Biomarkers help predict viable candidates for successful chemotherapy treatment for stage II colon cancer.

Nanoparticles selectively target tumor vessels or cancerous cells.

Stimulator of interferon gene agonists may offer hope in the treatment of in lymphoma, multiple myeloma, and certain forms of leukemia.

Genetic and molecular specialized testing may improve targeted therapy for skin cancer.

New generation of oncology drugs could improve treatment for patients with therapy-resistant cancer.

Recent advances and updates in oncology and cancer drug development.

The targeted multi-kinase inhibitor sorafenib is the standard of care for advanced HCC, but it has limited therapeutic benefit.

Nanoparticles can change shape to gain entry into diseased tissue and reduce the toxic effects of chemotherapy.

Investigational drug MLN8237 aids ABT-199 in killing neuroblastoma tumors in advanced mouse models.

Twitter can increase awareness and patient recruitment for clinical trials of cancer drugs.

Prostate specific membrane antigens offers new targets for potential prostate cancer drugs.

Histologic improvement greater with experimental drug versus placebo in patients with moderate-to-severe ulcerative colitis.

Study estimates health insurers can save $9.1 million over 5 years per 100 CML patients.

Out-of-pocket costs can lead to the reduced use of preventive services and increased use of preventive medications.

New treatment approach offers less severe side effects from chemotherapy.

Study finds incidence of post-traumatic stress symptoms in breast cancer patients to be underestimated.

Cell-based therapy shows promise in high-grade glioma.

Gene overexpressed in AML may offer new target for halting the spread of cancer.

Hops in beer contain antibacterial and anti-fungal properties, which could halt the growth of diseases.

Alcohol can affect estrogen in breast cancer cells and weakens the ability of drugs that halt proliferation.

Recent advances and updates in oncology and cancer drug development.

Herbal remedies such as stinging nettle, garlic, black cumin, and turmeric can cause harm during chemotherapy in some instances.

Advocacy group helps breast cancer patient overcome fear and channel her anger to battle the disease.

New technique uses chromatin as a way of identifying small molecule drugs for cancer.

Current standard treatment for advanced ovarian cancer is carboplatin, paclitaxel, and bevacizumab.

Macrophages can penetrate the surrounding walls that protect pancreatic cancer from chemotherapy.